Skip to main content
. Author manuscript; available in PMC: 2025 Jun 1.
Published in final edited form as: Curr Osteoporos Rep. 2024 Apr 11;22(3):308–317. doi: 10.1007/s11914-024-00870-6

Table 1:

Genetic Testing platforms available for clinical testing

Genetic testing platform Genomic regions interrogated Type of genetic variations that can be detected When to consider using for disorders of low bone mass and increased bone fragility
DNA Sequencing Sanger sequencing Exonic regions and exon-intron boundaries of single or few genes SNV, indels Suspicion of clinical diagnosis of a particular disorder is strong and only one to few genes need to be sequenced (e.g., ALPL sequencing in HPP)
Gene panel testing using MPS Exonic regions and exon-intron boundaries of few to hundreds of genes known to cause particular type of human diseases SNV, indels, CNV of genes included in the panel Clinical findings can narrow down the diagnostic category, but genetic heterogeneity necessitates interrogation of multiple genes (e.g., osteogenesis imperfecta gene panel in individuals with severe OI)
Exome sequencing Exonic regions and exon-intron boundaries of thousands of genes known to cause human diseases SNV, indels, CNV of exonic regions of genome Multisystem disorder; phenotype is not distinct to make a diagnosis or narrow down to a diagnostic category; undiagnosed diseases
Whole genome sequencing Whole genome SNV, indels, CNV and other genomic rearrangements in coding and non-coding regions of genome Multisystem disorder; phenotype is not sufficient to make a diagnosis or narrow down to a diagnostic category; undiagnosed diseases
DNA genotyping microarray Specific variants in few to hundreds of genes Targeted assessment of specific variations in the genome Polygenic risk scoring
Cytogenetic testing Karyotype Chromosomes Chromosomal aneuploidy, large chromosomal deletions, duplications, and rearrangements Hypogonadism and features suggestive of sex chromosome disorders (e.g., Turner syndrome and Klinefelter syndrome)
Chromosomal Microarray Genomic regions that harbor genes known to be associated with human diseases Chromosomal aneuploidy, and CNV including small chromosomal deletions, duplications, and complex genomic rearrangements Multisystem disorder, undiagnosed diseases

CNV - copy-number variation; HPP – hypophosphatasia; MPS - massively parallel sequencing; OI osteogenesis imperfecta